Get the Stockscreener App
1.76
10.94%
0.16
iBio Inc stock is traded at $1.76, with a volume of 3.06M.
It is up +10.94% in the last 24 hours and up +106.52% over the past month.
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$1.60
Open:
$1.65
24h Volume:
3.06M
Relative Volume:
1.00
Market Cap:
$34.79M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.2654
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
+38.67%
1M Performance:
+106.52%
6M Performance:
+75.74%
1Y Performance:
-33.52%
1-Day Range:
$1.61
$1.81
1-Week Range:
$1.24
$1.81
52-Week Range:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
Name
iBio Inc
Sector
Industry
Phone
302-355-0650
Address
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
1.77 | 32.41M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.29 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.61 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.65 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
823.27 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.17 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Oppenheimer | Outperform |
| Oct-17-25 | Initiated | Leerink Partners | Outperform |
| May-28-24 | Initiated | Chardan Capital Markets | Buy |
| Nov-29-21 | Initiated | JMP Securities | Mkt Outperform |
| Jan-22-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-26-20 | Initiated | Alliance Global Partners | Buy |
View All
iBio Inc Stock (IBIO) Latest News
Key metrics from iBio Inc.’s quarterly dataJuly 2025 Decliners & Verified Short-Term Plans - newser.com
Using AI based signals to follow iBio Inc.Market Performance Report & Daily Stock Momentum Reports - newser.com
Can trapped investors hope for a rebound in iBio Inc.Swing Trade & Daily Price Action Insights - newser.com
Why iBio Inc. stock appeals to dividend seekersDip Buying & Stock Portfolio Risk Management - newser.com
How iBio Inc. (0JV0) stock responds to job market shiftsJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - newser.com
Why iBio Inc. stock is rated strong buy2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com
Why analysts raise outlook for iBio Inc. (0JV0) stockProduct Launch & Verified Momentum Stock Alerts - newser.com
Why iBio Inc. (0JV0) stock trades below fair valueTrade Exit Report & Free AI Powered Buy and Sell Recommendations - newser.com
What high frequency data says about iBio Inc.Weekly Profit Analysis & AI Powered Market Entry Strategies - newser.com
Is iBio Inc. stock attractive for long term wealth buildingQuarterly Profit Review & Safe Entry Trade Reports - newser.com
Does iBio Inc. (0JV0) stock trade below intrinsic valueTrend Reversal & Low Risk Entry Point Guides - newser.com
Why iBio Inc. (0JV0) stock could be next leader2025 Market Trends & Scalable Portfolio Growth Methods - newser.com
What to expect from iBio Inc. in the next 30 daysJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
How iBio Inc. (0JV0) stock compares with market leadersEarnings Recap Summary & Smart Money Movement Alerts - newser.com
Analyzing iBio Inc. with multi timeframe chartsJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
iBio Inc. stock retracement – recovery analysis2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Using flow based indicators on iBio Inc.2025 Earnings Impact & Free Long-Term Investment Growth Plans - newser.com
Risk vs reward if holding onto iBio Inc.Portfolio Return Report & Entry and Exit Point Strategies - newser.com
iBio Inc (0JV0.BE) stock price, news, quote and history - Yahoo! Finance UK
Wave, Ibio activin E action in obesity early but solid - BioWorld MedTech
Roth MKM Sticks to Its Buy Rating for Ibio (IBIO) - The Globe and Mail
iBio Unveils Promising Preclinical Data for IBIO-610 - The Globe and Mail
Real time pattern detection on iBio Inc. stockWeekly Risk Report & Entry Point Confirmation Signals - newser.com
How buybacks impact iBio Inc. stock valueEarnings Risk Report & Stepwise Trade Execution Plans - newser.com
Oppenheimer Maintains IBio Inc(IBIO.US) With Buy Rating, Raises Target Price to $6 - 富途牛牛
iBio Inc Stock (IBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):